Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease.

Date publication

septembre 2024

Journal

Journal of Crohn's & colitis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Parigi TL, Massimino L, Carini A, Gabbiadini R, Bertoli P, Allocca M, Bezzio C, Dal Buono A, D'Amico F, Furfaro F, Loy L, Zilli A, Ungaro F, Jairath V, Peyrin-Biroulet L, Armuzzi A, Danese S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39269323

Résumé

Criteria for "difficult-to-treat" Inflammatory Bowel Disease (IBD) (DTT-IBD) have recently been proposed to standardize terminology. We aimed to evaluate the prevalence, characteristics, management, and outcomes of DTT-IBD.

Mots clés

Crohn’s disease, difficult to treat, inflammatory bowel disease, refractory, ulcerative colitis

Référence

J Crohns Colitis. 2024 09 12;: